Recruiting OBSERVATIONAL NCT06183762

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

Real-World Treatment Patterns and Effectiveness of Targeted and Systemic Therapy in Patients With Advanced Lung Cancer Carrying MET Mutation-Positive

Sponsor: Hunan Province Tumor Hospital

Conditions Advanced Lung Cancer

Interventions No treatment is included in this protocol.

Updated 4 times since 2024 Last updated: Sep 17, 2024 Started: Jan 1, 2020 Primary completion: Dec 31, 2024 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Advanced Lung Cancer and is currently actively recruiting participants. Hunan Province Tumor Hospital leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Oct 2024 — Present [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hunan Province Tumor Hospital

Data source: Hunan Province Tumor Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changsha, China